Last reviewed · How we verify
EMB07
At a glance
| Generic name | EMB07 |
|---|---|
| Sponsor | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EMB07 CI brief — competitive landscape report
- EMB07 updates RSS · CI watch RSS
- Shanghai EpimAb Biotherapeutics Co., Ltd. portfolio CI